Cover Image

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial

Saved in:
Bibliographic Details
Main Authors: Cherney, David Z., Dekkers, Claire C. J., Barbour, Sean J., Cattran, Daniel, Gafor, Abdul Halim Abdul, Greasley, Peter J., Laverman, Gozewijn D., Lim, Soo Kun, Di Tanna, Gian Luca, Reich, Heather N., Vervloet, Marc G., Wong, Muh Geot, Gansevoort, Ron T., Heerspink, Hiddo J. L., Investigators, DIAMOND
Format: Article
Published: Elsevier Science Inc 2020
Subjects:
R Medicine (General)
Online Access:http://eprints.um.edu.my/37566/
Tags: Add Tag
No Tags, Be the first to tag this record!
id my.um.eprints.37566
record_format eprints
spelling my.um.eprints.375662023-02-09T07:06:26Z http://eprints.um.edu.my/37566/ Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial Cherney, David Z. Dekkers, Claire C. J. Barbour, Sean J. Cattran, Daniel Gafor, Abdul Halim Abdul Greasley, Peter J. Laverman, Gozewijn D. Lim, Soo Kun Di Tanna, Gian Luca Reich, Heather N. Vervloet, Marc G. Wong, Muh Geot Gansevoort, Ron T. Heerspink, Hiddo J. L. Investigators, DIAMOND R Medicine (General) Elsevier Science Inc 2020-07 Article PeerReviewed Cherney, David Z. and Dekkers, Claire C. J. and Barbour, Sean J. and Cattran, Daniel and Gafor, Abdul Halim Abdul and Greasley, Peter J. and Laverman, Gozewijn D. and Lim, Soo Kun and Di Tanna, Gian Luca and Reich, Heather N. and Vervloet, Marc G. and Wong, Muh Geot and Gansevoort, Ron T. and Heerspink, Hiddo J. L. and Investigators, DIAMOND (2020) Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial. Lancet Diabetes & Endocrinology, 8 (7). pp. 582-593. ISSN 2213-8587,
institution Universiti Malaya
building UM Library
collection Institutional Repository
continent Asia
country Malaysia
content_provider Universiti Malaya
content_source UM Research Repository
url_provider http://eprints.um.edu.my/
topic R Medicine (General)
spellingShingle R Medicine (General)
Cherney, David Z.
Dekkers, Claire C. J.
Barbour, Sean J.
Cattran, Daniel
Gafor, Abdul Halim Abdul
Greasley, Peter J.
Laverman, Gozewijn D.
Lim, Soo Kun
Di Tanna, Gian Luca
Reich, Heather N.
Vervloet, Marc G.
Wong, Muh Geot
Gansevoort, Ron T.
Heerspink, Hiddo J. L.
Investigators, DIAMOND
Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial
format Article
author Cherney, David Z.
Dekkers, Claire C. J.
Barbour, Sean J.
Cattran, Daniel
Gafor, Abdul Halim Abdul
Greasley, Peter J.
Laverman, Gozewijn D.
Lim, Soo Kun
Di Tanna, Gian Luca
Reich, Heather N.
Vervloet, Marc G.
Wong, Muh Geot
Gansevoort, Ron T.
Heerspink, Hiddo J. L.
Investigators, DIAMOND
author_facet Cherney, David Z.
Dekkers, Claire C. J.
Barbour, Sean J.
Cattran, Daniel
Gafor, Abdul Halim Abdul
Greasley, Peter J.
Laverman, Gozewijn D.
Lim, Soo Kun
Di Tanna, Gian Luca
Reich, Heather N.
Vervloet, Marc G.
Wong, Muh Geot
Gansevoort, Ron T.
Heerspink, Hiddo J. L.
Investigators, DIAMOND
author_sort Cherney, David Z.
title Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial
title_short Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial
title_full Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial
title_fullStr Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial
title_full_unstemmed Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (DIAMOND): A randomised, double-blind, crossover trial
title_sort effects of the sglt2 inhibitor dapagliflozin on proteinuria in non -diabetic patients with chronic kidney disease (diamond): a randomised, double-blind, crossover trial
publisher Elsevier Science Inc
publishDate 2020
url http://eprints.um.edu.my/37566/
_version_ 1758578642082856960
score 13.211869

Similar Items